alz.org|Find Your Chapter  

AdvocateWalkShopDonate

Find your chapter:

search by state







Plus on Google Plus

African Americans and Alzheimer's

alz.org | IHaveAlz

There is a critical need for African-American clinical trial participants. Join a study today and help move research forward tomorrow.



African-Americans Leading the Way

These Champions have furthered groundbreaking preventative research, made strides in care and support, and raised awareness of Alzheimer’s disease in the hopes of finding a cure.



Dr. Solomon Carter Fuller

Solomon Carter Fuller, M.D., was the first known black psychiatrist in America and a pioneer among Alzheimer’s Champions. Born in Liberia, Dr. Fuller graduated from Boston University School of Medicine and conducted further research in Germany. He worked with Dr. Alois Alzheimer and toiled to translate much of his work from German to English. Dr. Fuller then practiced at Westborough State Mental Hospital in Massachusetts. Throughout his career, he pioneered revolutionary research on the physical changes in the brains of those with Alzheimer’s.


Dr. Monica Parker

Monica W. Parker, M.D., is an Assistant Professor of Medicine in the Division of Geriatrics and Gerontology at Emory University. A family physician with broad clinical experience in private and academic settings, she is a graduate of the University of Nebraska Medical Center. She has expanded her skills by completing both Stanford University’s “Geriatrics in Primary Care” and Morehouse School of Medicine Faculty Development Programs. Dr. Parker received a National Institute of Health (NIH) Minority Supplement award to study dementia in ethnic persons in the Emory Alzheimer’s Disease Research Center (ADRC). She is currently a CO-PI on a 3.5 million dollar grant awarded to Emory School of Nursing by the NIH - National Institute of Nursing Research (NINR).


Dr. Goldie Byrd

Dr. Goldie Byrd

Goldie Byrd , M.D., is the Nathan F. Simms Endowed professor of biology at North Carolina A&T State University, where she served as chair of biology for six years. She is also an adjunct professor of genetics at Duke. Dr. Byrd partners with colleagues at the University of Miami, Vanderbilt and Columbia to understand the genetic epidemiology of Alzheimer’s disease in African-Americans. Dr. Byrd has also been published extensively and presented her findings on African-American incentives and barriers to research participation at the Alzheimer’s Association International Conference on Alzheimer’s Disease 2009 (ICAD) in Vienna, Austria.


Warachal Faison, M.D.

Dr. Warachal Fasion

Warachal Faison, M.D., is a geriatric psychiatrist currently serving as a medical director in Neuroscience Primary Care at Pfizer Inc. For more than 15 years, she has studied the impact of Alzheimer’s disease on the African-American community, including minority recruitment for clinical trials. Dr. Faison, a proponent of community education and active discussion, participated in the Alzheimer’s Association Diversity Dialogue during the Alzheimer’s Action Summit in Washington, D.C. March 7-9, 2010.

> Learn more about brain health


Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.